Tag: Diabetes
Diabetes, weight loss drugs cause spike in spending, utilization
December 23, 2024HME News Staff
WASHINGTON – Medicaid spending on 10 selected diabetes and two selected weight loss drugs totaled more than $9 billion in 2023, a 540% increase compared to 2019, according to a new Data Brief from the Office of Inspector General.
“This substantial increase could have a financial impact on the Medicaid program,” the brief states. “Information in this data brief may be beneficial to CMS and State Medicaid agencies when developing future program guidance related to these...
Stakeholders push two-channel option for CGMs
November 27, 2024Theresa Flaherty, Managing Editor
WASHINGTON – Users of continuous glucose monitors have reported difficulties obtaining equipment and supplies when their insurers eliminate coverage under DME, adding more evidence that there needs to be a two-channel option, stakeholders say.
As CMS has expanded coverage of CGMs and supplies, some payers have begun making it a pharmacy-only benefit, limiting brand choices and narrowing networks.
“One patient wrote that they attempted to obtain sensors from three different...
In brief: Henry Schein makes CGM play, diabetes tech integrates, Medicare overpays & more
November 22, 2024HME News Staff
MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue.
Along with its previous acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, Henry Schein now expects its home medical supply platform to have annual revenue of about $350 million.
“As the delivery of health care in the U.S. is...
Dexcom partners with, invests in, Ōura
November 21, 2024HME News Staff
SAN DIEGO & SAN FRANCISCO – Dexcom’s glucose data with be integrated with the Oura Ring’s vital sign, sleep, stress, heart health and activity data to provide users of both products with a more complete picture of overall health, the companies say. Dexcom is also making a $75 million strategic investment in Ōura’s Series D funding, putting the company’s valuation at more than $5 billion. “Dexcom offers the most accurate glucose biosensing systems on the market...
Insulet’s Omnipod integrates with Libre
November 21, 2024HME News Staff
ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring sensor in the U.S. “We are excited to announce that Omnipod 5, the only AID system indicated for both Type 1 and Type 2 diabetes, is now integrated with Abbott’s FreeStyle Libre 2 Plus sensor in the U.S.,” aid Eric Benjamin, Insulet’s executive vice president and chief product and customer experience officer....
Medtronic’s InPen app gets FDA clearance
November 21, 2024HME News Staff
GALWAY, Ireland - Medtronic has received clearance from the U.S. Food and Drug Administration for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor. With this clearance, the system will be the first in the market to recommend corrections for missed or inaccurate insulin doses, providing real-time, personalized insights for individuals on multiple daily injection therapy, the company says. ...
Henry Schein expands supplies platform with Acentus
November 20, 2024HME News Staff
MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue.
Along with its previous acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, Henry Schein now expects its home medical supply platform to have annual revenue of about $350 million.
“As the delivery of health care in the U.S. is...
AdaptHealth targets diabetes business for improvement
November 8, 2024Theresa Flaherty, Managing Editor
PLYMOUTH MEETING, Pa. – AdaptHealth CEO Suzanne Foster is doubling down on efforts to turn around the company’s struggling diabetes business, saying it was “worse” than she initially thought it was.
The product category, which makes up 17% of the AdaptHealth’s revenues, declined 11.8% during the third quarter, following a worse than expected performance during the second quarter.
“Following last quarter's results, I turned my attention to...
Insulet sees ‘robust’ Q3
November 8, 2024HME News Staff
ACTON, Mass. – Insulet reported revenue of $543.9 million for the third quarter of 2023, an increase of 25.7%. Total Omnipod revenue was $533.6 million, an increase of 26.4%; of that, U.S. Omnipod revenue was $395.6 million and international Omnipod revenue was $138 million. “We continue to achieve significant milestones and robust revenue growth," said Jim Hollingshead, president and CEO. “Omnipod 5 is the first and only automated insulin delivery system in the U.S. for both...
Insulet to mark National Diabetes Awareness month
November 6, 2024HME News Staff
ACTON, Mass. – Insulet will recognize National Diabetes Awareness Month and World Diabetes Day with a series of activities in November. The company will sponsor the American Diabetes Association’s two-day community event Nov. 22 – 23 in Boston and will exhibit at the ADA Community Day of Access, which includes free health care screenings and more. “People with diabetes must make dozens of decisions every day to manage their condition, which can be incredibly stressful, overwhelming...